Unconstitutionality of the absolute prohibition of the commercialization of cannabis
Executive Summary:
- The First Chamber of the Supreme Court issued the thesis “Absolute prohibition of the commercialization of cannabis classified as a narcotic. Articles 234, 235 and 235 bis of the General Health Law that establish it violate the human rights to freedom of trade and work.".
- It was decided that the absolute prohibition of the commercialization of cannabis violates the rights to freedom of trade and work by not passing the proportionality test and the degree or sub-principle of necessity.
- This precedent lays the groundwork for the creation of a new market for the marketing of cannabis between producers and the general public.
On March 3, 2023, the thesis 1a. III/2023 (11a.) under the heading “Absolute prohibition of the commercialization of cannabis classified as a narcotic. Articles 234, 235 and 235 bis of the General Health Law that establish it violate the human rights to freedom of trade and work." issued by the First Chamber of the Supreme Court of Justice of the Nation when resolving the amparo review 461/2020 (available at the following link: https://sjf2.scjn.gob.mx/detalle/tesis/2026073).
In this precedent, it is determined that the content of articles 234, 235 and 235 Bis of the General Health Law has a negative impact on the fundamental rights to commerce and work, since it constitutes an obstacle for individuals to lawfully exercise the actions of commercialization of hemp classified as a narcotic, considering that the proportionality test is not passed, in its nuance of necessity.
In this regard, the Supreme Court considered that the absolute prohibition of the commercialization of cannabis is an unnecessary measure, since it absolutely prevents its commercialization for industrial purposes, when in order to achieve the objectives intended by the prohibition (protection of health) it could be limited to implementing a series of measures similar to those provided for medical and/or scientific purposes, such as authorization, monitoring, control, prevention and phytosanitary measures.
Likewise, it is relevant to note that when resolving the amparo in review 461/2020, the First Chamber of the Supreme Court of Justice of the Nation issued a diverse thesis of the heading "Absolute prohibitions contained in the General Health Law on different activities related to cannabis or marijuana. Scope of application of the proportionality test”, available at the following link: https://sjf2.scjn.gob.mx/detalle/tesis/2026074).
In this precedent, it was determined that although it has been the criterion of the Supreme Court that legislative restrictions that affect economic freedoms must be controlled by an ordinary test or one of mere reasonableness, which is less demanding than the proportionality test, in the case of the regulatory circuit established in the General Health Law related to cannabis, it must be specified that this standard of lax scrutiny is applicable to that legislation to regulate an economic activity, not to prohibit it totally. In this sense, it was determined that in the case of absolute prohibitions contained in the General Health Law, it is appropriate to subject them to a proportionality test as opposed to the ordinary one.
Based on the above, we consider that the theses recently published by the Supreme Court and those that determined the legality of recreational cannabis use lay the foundations for the creation of a new market related to large-scale production and marketing of cannabis to the general public, provided that the limits established in the applicable legislation are complied with.
The above, given that the Supreme Court of Justice of the Nation, when applying the proportionality test, has been emphatic and consistent in determining that there are other, less burdensome, measures for the protection of people's health, with regard to the activities of the previous phases of the cannabis production chain and activities related to its commercialization.












